Leyang Wu
Changzhou, 213164, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 17 publications
From tumor targeting to tumor accessibility: surface-engineered bacteria as precision living therapeutics for translational medicine.
Journal: Journal of hematology & oncology
Published: April 13, 2026
Controlled pyroptosis of engineered macrophages enables biphasic antitumor via the release of oncolytic bacteria and inflammatory signals.
Journal: Cell reports
Published: September 18, 2025
Correction to "Dual-Engineered Macrophage-Microbe Encapsulation for Metastasis Immunotherapy".
Journal: Advanced materials (Deerfield Beach, Fla.)
Published: June 17, 2025
A "plug-and-display" nanoparticle based on attenuated outer membrane vesicles enhances the immunogenicity of protein antigens.
Journal: Journal of controlled release : official journal of the Controlled Release Society
Published: July 28, 2024
Dual-Engineered Macrophage-Microbe Encapsulation for Metastasis Immunotherapy.
Journal: Advanced materials (Deerfield Beach, Fla.)
Published: April 29, 2024
Programmable Bacteria with Dynamic Virulence Modulation System for Precision Antitumor Immunity.
Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: April 17, 2024
Camouflaging attenuated Salmonella by cryo-shocked macrophages for tumor-targeted therapy.
Journal: Signal transduction and targeted therapy
Published: September 08, 2023
Bulk and Single-Cell Transcriptome Analyses Revealed That the Pyroptosis of Glioma-Associated Macrophages Participates in Tumor Progression and Immunosuppression.
Journal: Oxidative medicine and cellular longevity
Published: June 15, 2022
A SARS-CoV-2 oral vaccine development strategy based on the attenuated Salmonella type III secretion system.
Journal: Journal of applied microbiology
Published: March 01, 2022
Bacterially mediated drug delivery and therapeutics: Strategies and advancements.
Journal: Advanced drug delivery reviews
Published: February 21, 2022
Macrophage-mediated tumor-targeted delivery of engineered Salmonella typhi murium VNP20009 in anti-PD1 therapy against melanoma.
Journal: Acta pharmaceutica Sinica. B
Published: January 26, 2022
Last Updated: 09/26/2026